Scranton Hematology Oncology — Scranton, Pennsylvania

Scranton Hematology Oncology is a clinical research site located in Scranton, Pennsylvania, United States 18510.

Crixeo Health Trust Score: 83/100 (GOOD). This profile has not yet been claimed by the site owner.

Scranton Hematology Oncology has participated in 40 clinical trials with 9 currently active.

Therapeutic areas: Extensive Stage Small Cell Lung Carcinoma, Recurrent Small Cell Lung Carcinoma, Neck Squamous Cell Carcinoma of Unknown Primary.

Sponsors: National Cancer Institute (NCI), NSABP Foundation Inc, GOG Foundation.

Sponsor Feasibility Report

Trust Score: 83/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Scranton Hematology Oncology?

Scranton Hematology Oncology has a Crixeo Trust Score of 83/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Scranton Hematology Oncology conducted?

Scranton Hematology Oncology has 40 clinical trials on record, with 9 currently active. Their work covers Extensive Stage Small Cell Lung Carcinoma, Recurrent Small Cell Lung Carcinoma, Neck Squamous Cell Carcinoma of Unknown Primary.

Is Scranton Hematology Oncology accredited by Crixeo Health?

Yes — Scranton Hematology Oncology holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about Scranton Hematology Oncology?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.